This product was modified with a glycosylation site of Asn359 in Fc region. The glycosylated antibody CNTO7363 has increased resistant to proteases and can be used in various diseases and disorders
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-399 | Recombinant Anti-GLP-1 Antibody | WB, Dot, FuncS | IgG |
MHH-399 | Recombinant Human Anti-GLP-1 Antibody | WB, ELISA, IHC, FuncS | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-399-F(E) | Recombinant Anti-GLP-1 Antibody Fab Fragment | Neut, WB, FuncS | Fab |
MHH-399-F(E) | Recombinant Human Anti-GLP-1 Antibody Fab Fragment | FC, Neut, Funcs | Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-399-S(P) | Recombinant Anti-GLP-1 Antibody scFv Fragment | ELISA, WB, FC, FuncS | scFv |
MHH-399-S(P) | Recombinant Human Anti-GLP-1 Antibody scFv Fragment | ELISA, WB, IP, FuncS | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-146CT | Anti-Human GLP-1R (Glucagon-like peptide receptor 1) Recombinant Antibody (PHD191 ) | ELISA | Human antibody |
TAB-146CT-S(P) | Anti-Human GLP-1R (Glucagon-like peptide receptor 1) Recombinant Antibody scFv Fragment (PHD191 ) | ELISA | Human antibody |
TAB-146CT-F(E) | Anti-Human GLP-1R (Glucagon-like peptide receptor 1) Recombinant Antibody Fab Fragment (PHD191 ) | ELISA | Human antibody |
There are currently no Customer reviews or questions for Gly-043LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.